Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113581
Status:
COMPLETED
Last Update Posted:
2014-02-19
First Post:
2005-06-09
Brief Title:
Safety Study of EMD 72000 in Combination With ECX Epirubicin Cisplatin and Capecitabine in Oesophagogastric Cancer
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany